查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138416

全球血管損傷治療市場-2022-2029

Global Vascular Injury Treatment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球血管損傷治療市場的增長取決於某些因素，例如隨著血管損傷數量的增加，對血管損傷治療的需求也在增加。隨著交通事故、犯罪和傷害的增加，血管損傷的發生率也隨之增加，對血管損傷的治療提出了需求。國家對創新和醫療保健行業的支持有所增加，有助於促進業務擴張。

主要醫療保健提供商之間的合作預計將在預測期內推動全球血管損傷治療市場

全球血管損傷治療市場預計將在預測期內顯著擴大，原因是與醫院的合作夥伴關係不斷增加，為心臟相關疾病提供臨床護理。例如，Mayo Clinic Health System 和 OU Children's Hospital 於 2019 年合作開展了一項罕見的心髒病研究。 （左心發育不全綜合徵）。此外，我們正在與世界各地的許多醫院合作，以解決罕見的心髒病。此外，我們還與五家左心發育不全綜合徵 (HLHS) 聯盟成員合作：梅奧診所、費城兒童醫院、洛杉磯兒童醫院、明尼蘇達兒童醫院和科羅拉多兒童醫院。 Mayo Clinic Health System 於 2018 年與 Eko 合作開發數據驅動技術，以幫助醫生識別潛在的高危心髒病。 Eko 和 Mayo Clinic 還宣布了構建和商業化基於機器的算法的計劃，以幫助診斷患者的低射血分數（弱心臟泵）。因此，將出現更多檢測心髒病的新技術，預計全球血管損傷治療市場將在預測期內快速擴張。根據世界衛生組織 (WHO) 的數據，每年有 1790 萬人死於心血管疾病。因此，預計在預測期內推動全球血管損傷治療市場增長的原因之一是心血管疾病患病率的增加。

與血管治療相關的高成本阻礙了血管損傷治療市場的增長

然而，預計阻礙全球血管損傷治療行業發展的主要原因之一是與血管疾病治療相關的高成本。例如，與外周動脈疾病 (PAD) 相關的非冠狀動脈手術的總費用為 729 美元。此外，降壓治療的平均費用為 313 美元，降脂治療的平均費用為 207 美元。此外，根據美國心臟協會 (AHA) 的數據，到 2035 年，美國心血管護理的總成本預計將超過 1.1 萬億美元。

行業分析

全球血管損傷治療市場根據波特五力分析、供應鏈分析、監管分析、定價分析、報銷分析、未滿足的需求和專利趨勢等各種行業因素對市場進行了深入分析。 .

全球血管損傷治療市場報告提供大約 40 多個市場數據表、45 多個圖表和 180 頁結構。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按傷病分類的市場細分
  • 按處理方法劃分的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 對高級治療的需求不斷增加
    • 限制因素
      • 缺乏有效的治療方法
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章受傷

  • 血栓形成
  • 挫傷/內膜瓣
  • 撕裂/撕裂
  • 抽搐
  • 動脈瘤和假性動脈瘤
  • 動靜脈瘺 (AV)
  • 其他

第 8 章治療

  • 修補血管成形術
  • 外側前路椎板切開術/靜脈切開術
  • 繞過移植
  • 血栓切除術
  • 解剖外徑旁路
  • 其他

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 11 章公司簡介

  • 克利夫蘭診所
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Massachusetts General Hospital
  • Heidelberg University Hospital
  • Royal Berkshire NHS Foundation Trust
  • Mayo Clinic Health System
  • Tenet Healthcare
  • Apollo Hospitals Enterprise Ltd.
  • Universal Health Services, Inc.
  • Mediclinic International
  • CHSPSC, LLC（*List Is Not Exhaustive）

第12章 重要考察

第13章 DataM

簡介目錄
Product Code: DMPH2589

Market Overview

Vascular Injury Treatment Market size was valued at US$ 3.04 billion in 2021 and is estimated to reach US$ 5.05 million by 2029, growing at a CAGR of 6.2% during the forecast period (2022-2029).

Vascular injury happens when a blood artery is damaged (artery and veins). In addition, vascular surgeons identify these injuries according to the type of wound that caused them, such as a blunt or penetrating injury. A blunt injury happens when a blood vessel is squeezed or crushed, while a penetrating injury occurs when a blood vessel is punctured, torn, or severed. Furthermore, a blunt or penetrating injury may result in a life-threatening hemorrhage. Blood clots can be severe if they break off and migrate to other areas of the body, such as the lungs and brain, resulting in ischemic strokes and pulmonary embolism. The most frequent cause of peripheral artery injury is blunt or penetrating damage to the extremities. These injuries, which damage the main arteries, nerves, and veins, may have negative impacts if they are not identified and handled immediately, leading to long-term injury and deformity.

Market Dynamics

The global vascular injury treatment market growth driven by certain factors such by the number of vascular injuries increases, so does the need for vascular injury care. When the number of traffic collisions, crime, and injuries increases, so does the incidence of vascular injury damage, providing a demand for vascular injury care. State support for innovation and the healthcare industry has been expanded, which has aided business expansion.

Partnerships between major healthcare providers, is expected to drive the global vascular injury treatment market during the forecast period

Owing to an increase in hospital partnerships to provide clinical treatments for heart-associated disorders, the global vascular injury care market is projected to expand significantly over the forecast period. For example, Mayo Clinic Health System and OU Children's Hospital partnered on rare heart disease research in 2019. (Hypoplastic Left Heart Syndrome). Furthermore, they are working with a wide number of hospitals around the world to combat rare heart disease. Furthermore, Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado partnered with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium participants, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado. Mayo Clinic Health System has collaborated with Eko in 2018 to develop data-driven technologies that would assist doctors in identifying potentially risky heart diseases. Eko and Mayo Clinic have also announced plans to build and commercialize a machine-based algorithm that will assist in the diagnosis of low ejection fraction in patients (a weak heart pump). As a result, the global vascular injury treatment market is projected to expand at a faster pace over the forecast period as more new technology for detecting heart disease is launched. According to the World Health Organisation, 17.9 million people die each year from cardiovascular disease. As a result, one of the reasons projected to fuel growth in the global vascular injury care market over the forecast period is the growing prevalence of cardiovascular disease.

High cost associated with vascular treatment hampering the growth of the vascular injury treatment market

However, one of the main reasons projected to hinder the development of the global vascular injury care industry is the high cost associated with vascular disease treatment. For eg, the total cost of non-coronary procedures linked to peripheral artery disease (PAD) is US$ 729. Furthermore, the average cost of antihypertensive treatment is USD 313, while the average cost of lipid-lowering therapy is USD 207. Furthermore, according to the American Heart Association (AHA), the overall cost of cardiovascular care in the U.S. is expected to exceed USD 1.1 trillion by 2035.

Industry Analysis

The global vascular injury treatment market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs and patent trends etc.

Segment Analysis

The bypass graft segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The bypass graft segment continues significant dominance due to features such as elevated occurrence rates and health problems associated with vascular diseases. The most serious vascular diseases include stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI). According to the National Institutes of Health (NIH), coronary heart disease affects approximately 14 million men and women in the United States. It is most prominent in people over the age of 65. Plaque, a waxy material that accumulates blood to the heart muscle inside the lungs, induces the condition. The most effective treatment for artery damage is a bypass graft to enhance poor blood supply to the heart. Individuals with obstructive coronary artery disease, a type of ischemic heart disease, can benefit from this surgery because it decreases the risk of serious complications. As a result, demand for bypass grafts is growing, propelling market growth over the projected period.

Geographical Analysis

North America region holds the largest market share of the global vascular injury treatment market

Throughout the forecast period, North America is anticipated to continue its dominance in the overall vascular injury treatment market. During the forecast period, the growing prevalence of vascular diseases is projected to be the major factor driving the market's overall growth. Furthermore, the geriatric population in the United States is increasing, which is expected to increase the demand for peripheral vascular care in the region. According to the Centers for Disease Control and Prevention (CDC), about 8.5 million individuals in the United States suffer from peripheral artery disease, with 12 percent -20 percent of those above the age of 60 suffering from the disease. These are also some of the major reasons maintaining the region's dominance.

Competitive Landscape

The vascular injury treatment market is moderately competitive, owing to the presence of major market players in the key regions such as US, China, India and others. The key vascular injury treatment players which are contributing to the growth of the global market include Cleveland Clinic, Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Mayo Clinic Health System, Tenet Healthcare, Apollo Hospitals Enterprise Ltd., Universal Health Services, Inc., Mediclinic International, CHSPSC, LLC among others.

Key Companies to Watch

Cleveland Clinic

Overview: Cleveland Clinic is a Cleveland, Ohio-based nonprofit clinical medical center. The Cleveland Clinic Foundation, a non-profit group founded in 1921 in Ohio, maintains and manages a 170-acre (69-hectare) complex in Cleveland, as well as 11 associated hospitals, 19 family health centers in Northeast Ohio, and hospitals in Florida and Nevada. Cleveland Clinic also runs two Cleveland Clinic Canada locations in Toronto and the Cleveland Clinic Abu Dhabi hospital outside of the United States.

Product Portfolio: Endovascular aneurysm repair (EVAR)- It is a minimally invasive aneurysm repair surgery. A surgeon makes a small incision in your groin and inserts a catheter (thin, flexible tube) into an artery.

The global Vascular Injury Treatment market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Injury
  • 3.2. Market Snippet by Treatment Methods
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing demand for advanced treatment methods
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of effective therapeutics
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Injury

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Segment
  • 7.3. Market Attractiveness Index, By Injury Segment
    • 7.3.1. Thrombosis
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Contusion/Intimal Flap
    • 7.3.3. Laceration/Transection
    • 7.3.4. Spasm
    • 7.3.5. Aneurysm and Pseudoaneurysm
    • 7.3.6. Arteriovenous (AV) Fistula
    • 7.3.7. Others

8. By Treatment Methods

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods Segment
  • 8.3. Market Attractiveness Index, By Treatment Methods Segment
    • 8.3.1. Patch Angioplasty
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Lateral Arteriorrhaphy/ Venorrhaphy
    • 8.3.3. Bypass Graft
    • 8.3.4. Thrombectomy
    • 8.3.5. Extraanatomic Bypass
    • 8.3.6. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Methods
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cleveland Clinic
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Massachusetts General Hospital
  • 11.3. Heidelberg University Hospital
  • 11.4. Royal Berkshire NHS Foundation Trust
  • 11.5. Mayo Clinic Health System
  • 11.6. Tenet Healthcare
  • 11.7. Apollo Hospitals Enterprise Ltd.
  • 11.8. Universal Health Services, Inc.
  • 11.9. Mediclinic International
  • 11.10. CHSPSC, LLC(*List Is Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us